{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:20:39Z","timestamp":1789755639420,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818103207016"],"award-info":[{"award-number":["JCYJ20220818103207016"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["2020B1212060077"],"award-info":[{"award-number":["2020B1212060077"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioadv.2026.214845","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:47:37Z","timestamp":1774514857000},"page":"214845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Engineering selenium-loaded NK\u2013bacterial hybrid vesicle activate innate and adaptive immunity for triple-negative breast cancer therapy"],"prefix":"10.1016","volume":"185","author":[{"given":"Dan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2026.214845_bb0005","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.214845_bb0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioadv.2026.214845_bb0015","doi-asserted-by":"crossref","first-page":"eadr4795","DOI":"10.1126\/sciimmunol.adr4795","article-title":"Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer","volume":"10","author":"Slattery","year":"2025","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214845_bb0020","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00262-022-03365-4","article-title":"Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages","volume":"72","author":"Ehlers","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214845_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1017\/S0029665122002658","article-title":"Selenium status and immunity","volume":"82","author":"Fairweather-Tait","year":"2023","journal-title":"Proc. Nutr. Soc."},{"issue":"15","key":"10.1016\/j.bioadv.2026.214845_bb0030","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/nano12152606","article-title":"Inhibiting metastasis and improving chemosensitivity via chitosan-coated selenium nanoparticles for brain cancer therapy","volume":"12","author":"Dana","year":"2022","journal-title":"Nanomaterials"},{"issue":"9","key":"10.1016\/j.bioadv.2026.214845_bb0035","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1021\/acsnano.9b10103","article-title":"Boosting natural killer cell-based cancer immunotherapy with selenocystine\/transforming growth factor-beta inhibitor-encapsulated nanoemulsion","volume":"14","author":"Liu","year":"2020","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.bioadv.2026.214845_bb0040","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.trecan.2023.08.003","article-title":"Selenoproteins and tRNA-Sec: regulators of cancer redox homeostasis","volume":"9","author":"DeAngelo","year":"2023","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214845_bb0045","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.chempr.2022.03.010","article-title":"Selective cellular probes for mammalian thioredoxin reductase TrxR1: rational design of RX1, a modular 1,2-thiaselenane redox probe","volume":"8","author":"Zeisel","year":"2022","journal-title":"Chem"},{"issue":"4","key":"10.1016\/j.bioadv.2026.214845_bb0050","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s12011-022-03279-3","article-title":"Selenium alleviates ammonia-induced splenic cell apoptosis and inflammation by regulating the interleukin family\/death receptor axis and Nrf2 signaling pathway","volume":"201","author":"Wang","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.bioadv.2026.214845_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.113092","article-title":"Safety of selenium exposure and limitations of selenoprotein maximization: molecular and epidemiologic perspectives","volume":"211","author":"Vinceti","year":"2022","journal-title":"Environ. Res."},{"issue":"9","key":"10.1016\/j.bioadv.2026.214845_bb0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12032-025-02965-1","article-title":"NK-derived exosomes in anti-tumor strategies","volume":"42","author":"Zhang","year":"2025","journal-title":"Med. Oncol."},{"issue":"46","key":"10.1016\/j.bioadv.2026.214845_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202306158","article-title":"Outer membrane vesicle-based nanohybrids target tumor-associated macrophages to enhance trained immunity-related vaccine-generated antitumor activity","volume":"35","author":"Liang","year":"2023","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.bioadv.2026.214845_bb0070","doi-asserted-by":"crossref","first-page":"16698","DOI":"10.1021\/acsnano.0c03776","article-title":"Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy immune activation and checkpoint inhibition","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.bioadv.2026.214845_bb0075","doi-asserted-by":"crossref","first-page":"2003572","DOI":"10.1002\/advs.202003572","article-title":"Bacteria-based cancer immunotherapy","volume":"8","author":"Huang","year":"2021","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.bioadv.2026.214845_bb0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.214845_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03870-5","article-title":"A novel biomimetic nanoplatform amplifies ferroptosis for specific cGAS-STING pathway activation to enhance hepatocellular carcinoma chemo-immunotherapy","volume":"23","author":"Peng","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"40","key":"10.1016\/j.bioadv.2026.214845_bb0090","doi-asserted-by":"crossref","first-page":"2409590","DOI":"10.1002\/adma.202409590","article-title":"A biomimetic autophagosomes-based nanovaccine boosts anticancer immunity","volume":"36","author":"Qu","year":"2024","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.bioadv.2026.214845_bb0095","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1039\/D5MH00644A","article-title":"Focused ultrasound-responsive artificial killer cells for enhanced closed-loop cancer immunotherapy","volume":"12","author":"Zhang","year":"2025","journal-title":"Mater. Horiz."},{"issue":"14","key":"10.1016\/j.bioadv.2026.214845_bb0100","doi-asserted-by":"crossref","first-page":"2107461","DOI":"10.1002\/smll.202107461","article-title":"Antigen capture and immune modulation by bacterial outer membrane vesicles as in situ vaccine for cancer immunotherapy post-photothermal therapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214845_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/acs.nanolett.9b02182","article-title":"Bioengineering bacterial vesicle-coated polymeric nanomedicine for enhanced cancer immunotherapy and metastasis prevention","volume":"20","author":"Chen","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214845_bb0110","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.2147\/IJN.S247426","article-title":"Selenium nanoparticles synthesized using (MH191156) show antiproliferative and anti-angiogenic activity against cervical cancer cells","volume":"15","author":"Rajkumar","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2026.214845_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.145738","article-title":"Hyperbaric oxygen augments chemodynamic effect induced by probiotic-derived selenium nanoparticles to enhance cancer immune checkpoint blockade therapy","volume":"474","author":"Li","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"16","key":"10.1016\/j.bioadv.2026.214845_bb0120","doi-asserted-by":"crossref","first-page":"23740","DOI":"10.1021\/acsami.5c03195","article-title":"Engineered NK exosomes captured antigens in situ for enhanced tumor immunotherapy","volume":"17","author":"Peng","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2026.214845_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.145738","article-title":"Hyperbaric oxygen augments chemodynamic effect induced by probiotic-derived selenium nanoparticles to enhance cancer immune checkpoint blockade therapy","volume":"474","author":"Li","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"2","key":"10.1016\/j.bioadv.2026.214845_bb0130","doi-asserted-by":"crossref","first-page":"20220115","DOI":"10.1002\/EXP.20220115","article-title":"Unraveling mitochondria-targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials","volume":"3","author":"Peng","year":"2023","journal-title":"Exploration"},{"issue":"30","key":"10.1016\/j.bioadv.2026.214845_bb0135","doi-asserted-by":"crossref","first-page":"2401264","DOI":"10.1002\/adfm.202401264","article-title":"Selenium nanoparticles enhance NK cell-mediated tumoricidal activity in malignant pleural effusion via the TrxR1-IL-18RAP-pSTAT3 pathway","volume":"34","author":"Liu","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"29","key":"10.1016\/j.bioadv.2026.214845_bb0140","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1021\/acs.nanolett.4c02657","article-title":"Reprogramming tumor-associated macrophages with a Se-based core-satellite nanoassembly to enhance cancer immunotherapy","volume":"24","author":"Zhang","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioadv.2026.214845_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114130","article-title":"Cross-linked selenolipoic acid nanoplatform modulates intracellular and extracellular reactive oxygen species for cancer immunotherapy","volume":"386","author":"Tan","year":"2025","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.bioadv.2026.214845_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102424","article-title":"Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity","volume":"24","author":"Moriya","year":"2021","journal-title":"Iscience"},{"issue":"1","key":"10.1016\/j.bioadv.2026.214845_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002371-200401000-00001","article-title":"Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells","volume":"27","author":"Do","year":"2004","journal-title":"J. Immunother."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:59:47Z","timestamp":1780430387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S2772950826001433"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214845","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering selenium-loaded NK\u2013bacterial hybrid vesicle activate innate and adaptive immunity for triple-negative breast cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.214845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214845"}}